Validation of an Automated Online Language Interpreting Tool - Phase Two.

NCT03538860 | Completed

• 2 other identifiers: 1131922R01HS024949
• Study Type: interventional
• Target: 114
• Locations: 1 country
• Sites: 1

Brief Summary

There is a pressing national need to provide higher-quality, more effectively accessible language interpretation services to improve the health outcomes of Americans who have limited English proficiency (LEP). This project addresses a critical component of this problem: The need to improve access to high quality, mental health services for diverse populations by improving the flow of clinical work across care settings (primary care and specialty care) through the use of innovative online asynchronous methods of language interpretation and clinical communication. The investigators are conducting a two phase study. The first phase is completed and involved developing and testing the interpreting tool. The second phase of the research is a clinical trial to compare two methods of cross-language psychiatric assessment.

Conditions

Mood Disorder; Anxiety Disorder; Substance Use Disorder; Chronic Medical Condition

Keywords

Telepsychiatry; AsynchronousTelepsychiatry; Automated Translation

Outcome Measures

Primary Outcomes (2)

• Diagnostic accuracy

  Diagnosis accuracy with respect to gold standard SCID for Method B will be evaluated against Method A.

  Measured at one time point by each psychiatrist, once both methods of interviews are completed in one day

• Diagnostic Inter-rater reliability

  Using independent assessments from four psychiatrists for each of the 100 method B interviews the investigators will also examine inter-rater reliability of Method B diagnosis.

  Measured at one time point by each psychiatrist, once both methods of interviews are completed in one day

Secondary Outcomes (3)

• Satisfaction ratings

  Measured at one time point by each psychiatrist, once both methods of interviews are completed in one day

• Interview and language interpretation quality

  Measured at one time point by each psychiatrist, once both methods of interviews are completed in one day

• Interview and language interpretation accuracy

  Measured at one time point by each psychiatrist, once both methods of interviews are completed in one day

Study Arms (2)

Method A first then Method B

OTHER

Conventional in-person interview with a psychiatrist with a live human interpreter with crossover to asynchronous telepsychiatry

Behavioral: Active comparator: Human interpreter; Behavioral: Intervention: Asynchronous Telepsychiatry

Method B first then Method A

OTHER

Asynchronous telepsychiatry - that is, video-recorded interviews that are subsequently processed with automated speech recognition and machine translation technologies, with crossover to conventional in-person interview with a psychiatrist with a live human interpreter

Behavioral: Active comparator: Human interpreter; Behavioral: Intervention: Asynchronous Telepsychiatry

Interventions

Active comparator: Human interpreter BEHAVIORAL

A Spanish-speaking patient is diagnostically assessed in-person by an English-speaking psychiatrist through a Spanish-speaking interpreter.

Method A first then Method B; Method B first then Method A

Intervention: Asynchronous Telepsychiatry BEHAVIORAL

A Spanish-speaking patient is interviewed in Spanish by a trained mental health interviewer. The interview is video-recorded in real-time, automatically translated into English with sub-titles added to the video file, and sent to a psychiatrist and to 3 English-speaking psychiatrists to asynchronously review the video and make a diagnosis.

Method A first then Method B; Method B first then Method A

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• aged 18 or older
• diagnosis of a mood disorder, anxiety disorder, or substance/alcohol abuse disorder(s)
• Diagnosis of a chronic medical condition
• referred by PCP or self-referral with PCP informed

You may not qualify if:

• less than 18 years
• imminent suicidal ideation and/or plans
• immediate violent intentions or plans
• significant cognitive deficits
• patient who's PCP recommends not participating.

Sponsors & Collaborators

• University of California, Davis: lead
• Agency for Healthcare Research and Quality (AHRQ): collaborator

Study Sites (1)

UC Davis Medical Center

Sacramento, California, 95817, United States

Location

Related Publications (2)

• Tougas H, Chan S, Shahrvini T, Gonzalez A, Chun Reyes R, Burke Parish M, Yellowlees P. The Use of Automated Machine Translation to Translate Figurative Language in a Clinical Setting: Analysis of a Convenience Sample of Patients Drawn From a Randomized Controlled Trial. JMIR Ment Health. 2022 Sep 6;9(9):e39556. doi: 10.2196/39556.

  PMID: 36066959 DERIVED

• Parish MB, Gonzalez A, Hilty D, Chan S, Xiong G, Scher L, Liu D, Sciolla A, Shore J, McCarron R, Kahn D, Iosif AM, Yellowlees P. Asynchronous Telepsychiatry Interviewer Training Recommendations: A Model for Interdisciplinary, Integrated Behavioral Health Care. Telemed J E Health. 2021 Sep;27(9):982-988. doi: 10.1089/tmj.2020.0076. Epub 2021 Jan 12.

  PMID: 33434453 DERIVED

MeSH Terms

Conditions

Mood Disorders; Anxiety Disorders; Substance-Related Disorders

Condition Hierarchy (Ancestors)

Mental Disorders; Chemically-Induced Disorders

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: CROSSOVER
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: March 1, 2018
• First Posted: May 29, 2018
• Study Start: November 14, 2017
• Primary Completion: July 31, 2021
• Study Completion: July 31, 2021
• Last Updated: October 14, 2021

Record last verified: 2021-10

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)